Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

NeoTherapeutics begins phase II Parkinson's disease trial of Neotrofin

April 2, 2001

Glycine-site NMDA receptor antagonists discovered at Gruenenthal

March 30, 2001

Voluntary withdrawal of injectable anesthesia drug by Organon

March 30, 2001

NPS and AstraZeneca join forces in drug development alliance

March 30, 2001

Neurotrophic agents discovered at Teijin presented in recent patent

March 29, 2001

German launch of antimigraine Almogran imminent

March 29, 2001

Progen and Griffith University to discover new compounds to treat inflammatory diseases

March 29, 2001

Caspase inhibitors emerge from Vertex R&D program

March 28, 2001

NeoTherapeutics to evaluate Neotrofin in spinal cord injury patients

March 28, 2001

ADIR discloses dual 5-HT reuptake inhibitors, 5-HT1A receptor antagonists/partial agonists

March 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....